In late 2023, the FDA added more than a dozen peptides including both BPC-157 and thymosin alpha 1 to its list of substances that should not be compounded because the agency has identified potential significant safety risks. For BPC-157, the agency warned that the peptide could trigger an immune response
Furthermore, BPC-157 has been investigated for its ability to counteract the damaging effects of various toxins and stressors, such as NSAIDs in gastric tissue models
Theres no clear understanding of why adequate levels of B12 are associated with a reduced risk of obesity, but there are a few theories 9-11 : B12 may influence how the body stores fat B12 is required for proper muscle protein, and low levels could interfere with recovery Insufficient B12 impairs red blood cell production and interferes with oxygen delivery to muscles Key takeaway: There is some evidence linking low B12 levels to a higher risk of obesity in children, adolescents, and adults, but the evidence is too weak to confirm a relationship
Supports Gut Health: Offer protective benefits to the gastrointestinal lining, potentially assisting in the management of conditions like ulcers or promoting overall gut integrity
How BPC-157 Works BPC-157 has no identified high-affinity receptor and no canonical endogenous ligand counterpart
